RaphaS Co., Ltd. (214260) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for RaphaS Co., Ltd. (214260:KRX), powered by AI.

Current Price
₩9,690
P/E Ratio
-17.8
Market Cap
86.5B
Sector
Healthcare
What is the RaphaS Co., Ltd. stock price forecast?

RaphaS Co., Ltd. is currently trading at ₩9,690. View real-time AI analysis on Alpha Lenz.

What is RaphaS Co., Ltd. insider trading activity?

View the latest insider trading data for RaphaS Co., Ltd. on Alpha Lenz.

What is RaphaS Co., Ltd.'s P/E ratio?

RaphaS Co., Ltd.'s P/E ratio is -17.8.

RaphaS Co., Ltd.

KRX · 214260
₩9,690
Ask about RaphaS Co., Ltd.'s future dividend policy...
Alpha Chat Insight

RaphaS Co., Ltd. trades at a P/E of -17.8 (undervalued) with modest ROE of -16.2%. 3Y revenue CAGR of 10.2% highlights clear growth momentum.

Ask for details

Company Overview

RaphaS Co., Ltd. is a prominent entity within the healthcare sector, primarily focusing on the research, development, and production of medical devices and innovative healthcare solutions. The company is engaged in creating cutting-edge technologies aimed at improving patient care and outcomes. With a strong emphasis on innovation, RaphaS Co., Ltd. explores various facets of medical technology, from diagnostic equipment to therapeutic devices, serving hospitals, clinics, and healthcare professionals worldwide. The firm strives to enhance efficiency and accuracy in medical practices, contributing significantly to advancements in health services. Operating within a highly regulated industry, RaphaS Co., Ltd. adheres to stringent compliance standards, ensuring its products' safety and efficacy. Its role is vital in promoting healthier lives and advancing medical knowledge through technological innovation and quality healthcare solutions. This positions RaphaS Co., Ltd. as a critical player in the global healthcare industry.

CEO정도현
SectorHealthcare
IndustryBiotechnology
Employees79

Company Statistics

FY 2024

Profile

₩86,458,666,470Market Cap
₩27,215,365,200Revenue
8.92MShares Out
79Employees

Margins

44.43%Gross
7.67%EBITDA
-12.72%Operating
-21.81%Pre-Tax
-21.31%Net

Valuation

-17.82P/E
2.90P/B
3.12EV/Sales
49.56EV/EBITDA
26.66P/FCF

Growth (CAGR)

10.19%Rev 3Yr
8.42%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-6.57%ROA
-16.20%ROE
-1.24%ROIC

Financial Health

₩14,415,312,990Cash & Cash Equivalents
₩30,047,663,820Net Debt
140.56%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

RaphaS Co., Ltd. (ticker: 214260) is a company listed on KRX in the Healthcare sector (Biotechnology). It has approximately 79 employees. Market cap is $86.5B.

The current price is ₩9,690 with a P/E ratio of -17.82x and P/B of 2.9x.

ROE is -16.20% and operating margin is -12.72%. Annual revenue is $27.2B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
RaphaS Co., Ltd. (Healthcare) Stock Forecast & Analysis ₩9,690 | Alpha Lenz